Patients with MAS demonstrate enhanced production of pro-inflammatory cytokines such as IL-1, IL-6, IL-18, IFN-γ, and tumor necrosis factor (TNF) or natural antagonists of these cytokines [32, 33]. This evidence concerns the gene IFNG and macrophage activation syndrome.